Gastroenterology and Liver

Gastrointestinal Disorders: Clinical Updates

Gastrointestinal disorders, including GERD, peptic ulcers, functional dyspepsia, and irritable bowel syndrome, continue to represent a significant burden on global healthcare systems. This session focuses on the latest advancements in understanding the pathophysiology, diagnostic approaches, and management strategies of these disorders. Clinicians and researchers will explore novel diagnostic tools, including endoscopic techniques, imaging modalities, and biomarker developments, which enhance early detection and precision management. Discussions will highlight both pharmacological and non-pharmacological interventions, including diet, lifestyle modifications, and emerging therapies aimed at improving patient outcomes. The session provides a platform to present recent clinical trials, systematic reviews, and meta-analyses that shed light on optimal treatment pathways.

In addition, this track emphasizes personalized approaches to gastrointestinal care, addressing the heterogeneity in patient responses and symptom presentation. Interactive case discussions will enable participants to examine real-world applications of updated clinical guidelines and integrate research findings into daily practice. The role of multidisciplinary teams in managing complex GI disorders, including collaboration with dietitians, psychologists, and surgeons, will be highlighted. Participants will also explore innovative therapeutic strategies, including the use of probiotics, microbiome modulation, and targeted drug delivery systems. Overall, this session seeks to bridge the gap between research and clinical practice, offering attendees actionable insights that can transform patient care in the field of gastroenterology.